The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better

The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better

IntroductionLuteal-phase ovarian stimulation has been proved to be feasible for producing competent oocytes/embryos and achieving live births, yet there is no standardized stimulation protocol for luteal-phase ovarian stimulation (LPS). The aim of this study was to explore the optimal timing of gona...

Full description

Bibliographic Details
Main Authors:	Jia Huang, Luxin Liu, Yue Wu, Benyu Miao, Yubin Li, Canquan Zhou, Yanwen Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Endocrinology
Subjects:	luteal phase stimulation timing of gonadotropin initiation duration of ovarian stimulation clinical outcome poor responder
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.979934/full

Similar Items

Conventional follicular-phase ovarian stimulation vs. luteal-phase stimulation in suboptimal responders: a randomized controlled trial
by: Jorge Suñol, M.D., et al.
Published: (2023-12-01)

Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial
by: Joaquín Llácer, et al.
Published: (2020-02-01)

Outcomes of High Initial Daily Doses of Gonadotropin in Patients With Poor Ovarian Reserve
by: Li-Ling Chou, et al.
Published: (2010-12-01)

Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study
by: Li-Hong Wei, et al.
Published: (2016-02-01)

Use of Human Chorionic Gonadotropin and Vaginal Progesterone Suppositories For Luteal Phase Support in Gonadotropin-Induced Cycles: A Comparative Study
by: Emel Ebru Özçimen, et al.
Published: (2006-04-01)

Comparison of luteal phase stimulation with follicular phase stimulation in poor ovarian response: a single-blinded randomized controlled trial
by: Mozhgan Vahabi Dastjerdi, et al.
Published: (2024-02-01)

Use of gonadotropins in ovarian stimulation in Spain: Delphi consensus
by: Gorka Barrenetxea, et al.
Published: (2023-12-01)

Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders
by: Yuan Liu, et al.
Published: (2021-01-01)

Comparison of ovarian stimulation in follicular and luteal phases in an ovarian cycle (DuoStim) in patients with poor ovarian response
by: Elham Naghshineh, et al.
Published: (2023-04-01)

Influence of the starting day of luteal phase stimulation on double stimulation cycles
by: Ana Fuentes, et al.
Published: (2023-07-01)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
by: Kazuhiro Takeuchi, et al.
Published: (2023-10-01)

Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
by: Raoul Orvieto, et al.
Published: (2021-05-01)

Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
by: Barbara Lawrenz, et al.
Published: (2018-02-01)

Retrospective study of influencing factors on the outcomes of luteal phase stimulation in patients with dual stimulation
by: Yuanyuan Chen, et al.
Published: (2023-05-01)

The value of urinary gonadotropins in the diagnosis of central precocious puberty: a meta-analysis
by: Dan Xu, et al.
Published: (2022-07-01)

Effect of luteal-phase support on endometrial microRNA expression following controlled ovarian stimulation
by: Zhao Yulian, et al.
Published: (2012-09-01)

Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs
by: E M Savelyeva, et al.
Published: (2016-06-01)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
by: Qiuju Chen, et al.
Published: (2019-11-01)

Ovarian stimulation in assisted reproductive technology cycles for varied patient profiles: An Indian perspective
by: Padma Rekha Jirge, et al.
Published: (2022-01-01)

The best execution of the DuoStim strategy (double stimulation in the follicular and luteal phase of the same ovarian cycle) in patients who are poor ovarian responders
by: Yanqun Luo, et al.
Published: (2020-10-01)

Insufficiency of luteal phase defect an assessment of criteria in patients with endocrine forms of infertility
by: A. G. Davudova
Published: (2016-06-01)

Functional and Morphological Characterization of Small and Large Steroidogenic Luteal Cells From Domestic Cats Before and During Culture
by: Michał M. Hryciuk, et al.
Published: (2019-11-01)

Impact of Luteinized Unruptured Follicles on Clinical Outcomes of Natural Cycles for Frozen/Thawed Blastocyst Transfer
by: Song Li, et al.
Published: (2021-10-01)

Investigating Ovulation Induction Outcomes in Patients with Decreased Ovarian Reserve Treated with Double Stimulation during The Follicular and Luteal Phases Compared to The Conventional Antagonist Cycle: A Randomized Clinical Trial
by: Fatemeh Ghahghayi, et al.
Published: (2024-04-01)

Luteal Support and Risk of Ovarian Hyperstimulation in Assisted Reproduction (A Review)
by: V. A. Krutova, et al.
Published: (2020-12-01)

Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges.
by: Jianping Ou, et al.
Published: (2015-01-01)

Clomiphene citrate or medroxyprogesterone acetate with human menopausal gonadotropin in poor responders during In vitro fertilization/intracytoplasmic sperm injection treatments combined with embryo cryopreservation?
by: Lu Fang, et al.
Published: (2019-01-01)

Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A prospective randomized trial
by: Leila Pourali, et al.
Published: (2017-01-01)

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
by: Imane Lalami, et al.
Published: (2022-06-01)

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
by: Sandro C. Esteves, et al.
Published: (2018-08-01)

The enigma of early progesterone rise: Is it associated with the type of gonadotropin used?
by: Abhijit A Oka, et al.
Published: (2019-01-01)

Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG
by: Lan N. Vuong, et al.
Published: (2020-03-01)

Impact of the Duration of Controlled Ovarian Stimulation on Assisted Reproduction Cycle Outcomes
by: Inci Kahyaoglu, et al.
Published: (2019-04-01)

The efficacy and safety of luteal phase support with progesterone following ovarian stimulation and intrauterine insemination: A systematic review and meta-analysis
by: G. Casarramona, et al.
Published: (2022-09-01)

Should human chorionic gonadotropine treatment increase thyroid volume?
by: Ayten Oguz, et al.
Published: (2015-08-01)

A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol
by: Yubin Li, et al.
Published: (2021-09-01)

Does double dose of recombinant human chorionic gonadotropin for final follicular maturation in in vitro fertilization cycles improve oocyte quality: A prospective randomized study
by: Neeta Singh, et al.
Published: (2019-01-01)

The effects of opium addicyion on testosterone and gonadotropins in addicted men
by: GH.R Sepehri, et al.
Published: (1995-03-01)

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
by: Moran Shapira, et al.
Published: (2020-06-01)

Prognostic factors associated with clinical pregnancy in in vitro fertilization using pituitary down-regulation with depot and daily low-dose luteal phase gonadotropin releasing hormone agonists: A single center′s experience
by: Caiyun Liao, et al.
Published: (2015-01-01)